Valuation: Takeda Pharmaceutical Company Limited

Market Cap 9,469B 60.16B 52.91B 50.03B 45.38B 85.22B 5,774B 85.72B 599B 231B 2,947B 226B 221B P/E 2027 *
47x
P/E 2028 * 29.8x
Enterprise Value 13,375B 84.97B 74.74B 70.67B 64.1B 120B 8,157B 121B 846B 327B 4,162B 319B 312B EV / Sales 2027 *
2.84x
EV / Sales 2028 * 2.75x
Free-Float
99.26%
Yield 2027 *
3.45%
Yield 2028 * 3.51%
1 day-0.65%
1 week-0.64%
Current month+2.86%
1 month+2.08%
3 months+16.57%
6 months+1.54%
Current year+22.65%
1 week 5,876
Extreme 5876
6,030
1 month 5,557
Extreme 5557
6,030
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 56 2024-12-31
Director of Finance/CFO 48 2024-03-31
Chief Tech/Sci/R&D Officer 47 2022-01-31
Director TitleAgeSince
Director/Board Member 60 2015-05-31
Director/Board Member 73 2018-12-31
Director/Board Member 48 2024-05-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/14/26 Sell

Executive/Senior Manager

-34,535 0.0022%
9/2/26 Sell

Chief Technology Officer

-116,191 0.0073%
8/19/26 Sell

Chief Technology Officer

-19,651 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-0.64%+33.62%+23.28% 60.57B
+0.11%+1.71%+63.08%+117.61% 1,055B
+0.27%+0.92%+49.74%+73.35% 654B
+0.73%+0.68%+19.32%+74.90% 467B
-1.36%-0.39%+40.20%+41.03% 348B
+1.34%+5.47%+23.37%+31.30% 275B
-0.48%-0.06%+13.56%+12.36% 258B
+0.85%+6.35%+52.62%+54.39% 224B
+0.85%+1.10%+35.15%+101.82% 187B
-0.30%-10.41%-27.62%-61.04% 171B
Average +0.25%+0.67%+30.30%+46.90% 369.89B
Weighted average by Cap. +0.29%+1.29%+39.93%+69.02%

Financials

2027 *2028 *
Net sales 4,704B 29.88B 26.28B 24.85B 22.54B 42.33B 2,868B 42.58B 298B 115B 1,464B 112B 110B 4,794B 30.46B 26.79B 25.33B 22.98B 43.15B 2,924B 43.4B 303B 117B 1,492B 114B 112B
Net income 196B 1.25B 1.1B 1.04B 942M 1.77B 120B 1.78B 12.43B 4.8B 61.15B 4.69B 4.59B 323B 2.05B 1.8B 1.71B 1.55B 2.9B 197B 2.92B 20.42B 7.89B 100B 7.7B 7.53B
Net Debt 3,907B 24.82B 21.83B 20.64B 18.72B 35.16B 2,382B 35.36B 247B 95.45B 1,216B 93.18B 91.16B 3,702B 23.52B 20.69B 19.56B 17.74B 33.32B 2,258B 33.51B 234B 90.45B 1,152B 88.31B 86.39B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
26-09-28 JP¥5,930.00 -0.65% 4,933,900
26-09-25 JP¥5,969.00 +1.43% 3,826,100
26-09-24 JP¥5,885.00 -1.39% 6,301,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
5,930.00JPY
Average target price
6,622.06JPY
Spread / Average Target
+11.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock